Aerovate Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Aerovate Therapeutics by Summit Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $1.6k | 772 | 2.09 |
2024-06-30 | $1.3k | 772 | 1.66 |
2024-03-31 | $23k | 772 | 29.57 |
2023-12-31 | $18k | 772 | 22.63 |
2023-09-30 | $11k | 772 | 13.57 |
2023-06-30 | $13k | 772 | 17.15 |
2023-03-31 | $16k | 772 | 20.17 |
2022-12-31 | $18k | 772 | 23.10 |
2022-09-30 | $12k | 772 | 15.54 |
2022-06-30 | $12k | 772 | 15.54 |
2022-03-31 | $14k | 772 | 18.13 |
2021-12-31 | $9.0k | 772 | 11.66 |
2021-09-30 | $16k | 772 | 20.73 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors